Skip to main content

Murphy Andrew J's Form 4 filing

Regeneron Pharmaceuticals, Inc. (REGN) · filed May 18, 2022

Accession no.
0001883850-22-000046
Filed
May 18, 2022
Trade date
May 16-17, 2022
Filing delay
2 days
Rule 10b5-1 plan
Not on the form (before 2023)

This filing lists 17 non-derivative transactions and 1 derivative transaction. Open-market sales total $2.35M. It was filed 2 days after the trade.

Reporting owners

A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.

Reporting owners on this filing
OwnerRelationship to the company
Murphy Andrew JCIK 0001796226Officer (EVP Research)

Non-derivative securities (Table I)

Acquisitions and disposals of common stock and similar shares, one row per line on the filing.

Non-derivative transactions
Trade dateSecurityTransactionSharesPriceValueShares afterOwnershipFlags
May 16, 2022Common StockMOption exerciseAcquired+10,000$179.13+$1,791,30068,470Direct
May 16, 2022Common StockFTax withholdingDisposed−6,457$648.31−$4,186,137.6762,013Direct
May 17, 2022Common StockSSaleDisposed−59$655.40−$38,668.661,954Direct
May 17, 2022Common StockSSaleDisposed−58$656.52−$38,078.1661,896Direct
May 17, 2022Common StockSSaleDisposed−60$657.51−$39,450.661,836Direct
May 17, 2022Common StockSSaleDisposed−123$658.56−$81,002.8861,713Direct
May 17, 2022Common StockSSaleDisposed−77$660.32F2−$50,844.6461,636Direct
May 17, 2022Common StockSSaleDisposed−465$661.46F3−$307,578.961,171Direct
May 17, 2022Common StockSSaleDisposed−779$662.57F4−$516,142.0360,392Direct
May 17, 2022Common StockSSaleDisposed−472$663.60F5−$313,219.259,920Direct
May 17, 2022Common StockSSaleDisposed−428$664.32F6−$284,328.9659,492Direct
May 17, 2022Common StockSSaleDisposed−126$665.36−$83,835.3659,366Direct
May 17, 2022Common StockSSaleDisposed−352$666.23F7−$234,512.9659,014Direct
May 17, 2022Common StockSSaleDisposed−154$667.49F8−$102,793.4658,860Direct
May 17, 2022Common StockSSaleDisposed−180$668.68F9−$120,362.458,680Direct
May 17, 2022Common StockSSaleDisposed−153$669.12F10−$102,375.3658,527Direct
May 17, 2022Common StockSSaleDisposed−57$670.49−$38,217.9358,470Direct

Derivative securities (Table II)

Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.

Derivative transactions
Trade dateSecurityTransactionUnderlying sharesUnit priceValueHeld afterOwnershipFlags
May 16, 2022Common StockMOption exerciseDisposed−10,000$0.00$020,000Direct

Footnotes and remarks

Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.

F2

Represents volume-weighted average price of sales of 77 shares of Company stock on May 17, 2022 at prices ranging from $660.18 to $660.72. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on May 17, 2022 at each separate price.

Referenced by the price of 1 transaction in Table I.

F3

Represents volume-weighted average price of sales of 465 shares of Company stock on May 17, 2022 at prices ranging from $661.16 to $661.93. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on May 17, 2022 at each separate price.

Referenced by the price of 1 transaction in Table I.

F4

Represents volume-weighted average price of sales of 779 shares of Company stock on May 17, 2022 at prices ranging from $662.29 to $662.89. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on May 17, 2022 at each separate price.

Referenced by the price of 1 transaction in Table I.

F5

Represents volume-weighted average price of sales of 472 shares of Company stock on May 17, 2022 at prices ranging from $663.20 to $663.80. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on May 17, 2022 at each separate price.

Referenced by the price of 1 transaction in Table I.

F6

Represents volume-weighted average price of sales of 428 shares of Company stock on May 17, 2022 at prices ranging from $664.01 to $664.80. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on May 17, 2022 at each separate price.

Referenced by the price of 1 transaction in Table I.

F7

Represents volume-weighted average price of sales of 352 shares of Company stock on May 17, 2022 at prices ranging from $666.11 to $666.93. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on May 17, 2022 at each separate price.

Referenced by the price of 1 transaction in Table I.

F8

Represents volume-weighted average price of sales of 154 shares of Company stock on May 17, 2022 at prices ranging from $667.27 to $667.86. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on May 17, 2022 at each separate price.

Referenced by the price of 1 transaction in Table I.

F9

Represents volume-weighted average price of sales of 180 shares of Company stock on May 17, 2022 at prices ranging from $668.41 to $668.88. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on May 17, 2022 at each separate price.

Referenced by the price of 1 transaction in Table I.

F10

Represents volume-weighted average price of sales of 153 shares of Company stock on May 17, 2022 at prices ranging from $669.00 to $669.21. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on May 17, 2022 at each separate price.

Referenced by the price of 1 transaction in Table I.

Read the full filing on SEC EDGAR (opens in a new tab)